Teva creates Global Specialty Medicines group

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) named Rob Koremans as president and CEO of the newly formed Global Specialty Medicines group. Koremans joined Teva last year as president and CEO of Tev...